Integral Health Asset Management’s Integra LifeSciences IART Stock Holding History

Integral Health Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.88M	Buy	+550,000	New	+$7.69M	0.39%	61

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Integral Health Asset Management's IART Position: Q2 2026 in Review

Integral Health Asset Management opened a new position in Integra LifeSciences (IART) in Q2 2026: 550,000 shares worth $9.88M. The stake represents 0.39% of the portfolio and ranks #61 among its holdings.

212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Integral Health Asset Management held 550,000 shares of Integra LifeSciences worth $9.88M as of Q2 2026.
Integra LifeSciences was a new Integral Health Asset Management position in Q2 2026.
Integra LifeSciences made up 0.39% of Integral Health Asset Management's portfolio in Q2 2026, its #61 holding.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.